Flindof™
Doxofylline INNXanthine derivatives (Antiasthma) Indication: Flindof™ (Doxofylline) is indicated for the treatment of bronchial asthma, pulmonary disease with spastic bronchial component and Chronic Obstructive Pulmonary Disease (COPD). Dosage & Administration: Adults: 400 mg tablet two or three times daily or as prescribed by a physician.Elderly: 200 mg tablet two or three times dailyMaximum Daily Dose: 1,200 mg.Lesser than […]